Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginFCF MarginInterest Coverage RatioNet MarginOperating MarginReturn on SalesTimes Interest Earned

GT Biopharma (GTBP) FCF Margin (2018 - 2021)

GT Biopharma (GTBP) has disclosed FCF Margin for 7 consecutive years, with 16840.91% as the latest value for Q4 2021.

  • On a quarterly basis, FCF Margin changed N/A to 16840.91% in Q4 2021 year-over-year; TTM through Dec 2021 was 70936.36%, a N/A change, with the full-year FY2025 number at 10157.48%, changed N/A from a year prior.
  • FCF Margin was 16840.91% for Q4 2021 at GT Biopharma, up from 13.28% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 16840.91% in Q4 2021 to a low of 13.28% in Q4 2019.
  • A 3-year average of 4263.62% and a median of 113.43% in 2018 define the central range for FCF Margin.